These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 24061692
1. Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs. Cong W, Shen L, Xu D, Zhao L, Ruan K, Feng Y. Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):203-10. PubMed ID: 24061692 [Abstract] [Full Text] [Related]
2. [Formula screening and optimizing for the dispersible tablets of breviscapine by orthogonal experiment]. Ding Y, Huang GH. Zhong Yao Cai; 2010 Mar; 33(3):455-8. PubMed ID: 20681316 [Abstract] [Full Text] [Related]
3. Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system. Ma Y, Li H, Guan S. Drug Dev Ind Pharm; 2015 Feb; 41(2):177-82. PubMed ID: 25113432 [Abstract] [Full Text] [Related]
4. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo. Yang M, He S, Fan Y, Wang Y, Ge Z, Shan L, Gong W, Huang X, Tong Y, Gao C. Int J Pharm; 2014 Nov 20; 475(1-2):97-109. PubMed ID: 25171976 [Abstract] [Full Text] [Related]
8. Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability. Feng BL, Li HW, Zhou MY, Lu W. Zhong Yao Cai; 2011 Apr 20; 34(4):605-10. PubMed ID: 21809547 [Abstract] [Full Text] [Related]
10. [Studies on solubility enhancement of curcumin by Polyvinylpyrrolidione K30]. Xu DH, Wang S, Mei XT, Luo XJ, Xu SB. Zhong Yao Cai; 2008 Mar 20; 31(3):438-42. PubMed ID: 18619253 [Abstract] [Full Text] [Related]
13. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process. Ha ES, Kim JS, Baek IH, Yoo JW, Jung Y, Moon HR, Kim MS. Drug Des Devel Ther; 2015 Mar 20; 9():4269-77. PubMed ID: 26345723 [Abstract] [Full Text] [Related]
16. Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies. Li W, Yi S, Wang Z, Chen S, Xin S, Xie J, Zhao C. Int J Pharm; 2011 Nov 25; 420(1):161-71. PubMed ID: 21884770 [Abstract] [Full Text] [Related]
17. Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept. Hou P, Ni J, Cao S, Lei H, Cai Z, Zhang T, Yu F, Tan Q. AAPS PharmSciTech; 2013 Jun 25; 14(2):629-38. PubMed ID: 23636816 [Abstract] [Full Text] [Related]
18. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability. Zhang F, Mao J, Tian G, Jiang H, Jin Q. AAPS PharmSciTech; 2022 Jan 31; 23(1):65. PubMed ID: 35102461 [Abstract] [Full Text] [Related]
20. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies. Sawicki E, Schellens JH, Beijnen JH, Nuijen B. Drug Dev Ind Pharm; 2017 Apr 31; 43(4):584-594. PubMed ID: 28010129 [Abstract] [Full Text] [Related] Page: [Next] [New Search]